Artiva Biotherapeutics, Inc. (ARTV) stock
ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.86−0.10 (-2.53%)
Close on Nov 17, 2026Market cap $188.72MP/E –Yield –
Artiva Biotherapeutics total assets
Total assets on the balance sheet at the end of each period.
Artiva Biotherapeutics's total assets was $368.63M at Jun 30, 2026. For fiscal 2025 it was $130.94M, down 37.5% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $130.94M | -37.5% |
| FY2024 | Dec 31, 2024 | $209.58M | +99.4% |
| FY2023 | Dec 31, 2023 | $105.11M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $368.63M | +117.6% |
| Q1 FY2026 | Mar 31, 2026 | $105.96M | -44.6% |
| Q4 FY2025 | Dec 31, 2025 | $130.94M | -37.5% |
| Q3 FY2025 | Sep 30, 2025 | $148.86M | -34.0% |
| Q2 FY2025 | Jun 30, 2025 | $169.39M | +123.1% |
| Q1 FY2025 | Mar 31, 2025 | $191.26M | +82.0% |
| Q4 FY2024 | Dec 31, 2024 | $209.58M | – |
| Q3 FY2024 | Sep 30, 2024 | $225.60M | – |
| Q2 FY2024 | Jun 30, 2024 | $75.91M | – |
| Q4 FY2023 | Dec 31, 2023 | $105.11M | – |
See a number that looks wrong?